Oxurion Receives Transparency Notifications from Negma Group February 24, 20230CommentsEN NL Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA February 24, 20230CommentsEN NL Read More
Oxurion Receives Transparency Notifications from Negma Group February 17, 20230CommentsEN NL Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA February 17, 20230CommentsEN NL Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA February 10, 20230CommentsEN NL Read More
Oxurion Receives Transparency Notifications from Negma Group February 3, 20230CommentsEN NL Read More
Oxurion Provides Further Details Concerning the Second Amendment to Negma Funding Program January 27, 20230CommentsEN Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA January 27, 20230CommentsEN NL Read More
Biotech Showcase @JPM Week 2023 – San Francisco, CA January 9, 20230CommentsJanuary 9 - January 11, 2023 Read More
Jaarverslag 2022 (officiële ESEF-versie) December 30, 20220CommentsJaarverslag 2022 (officiële ESEF-versie) Read More
Annual report 2022 (official ESEF version) December 30, 20220CommentsAnnual report 2022 (official ESEF version)Read More
Oxurion Receives Transparency Notifications from Negma Group December 21, 20220CommentsEN NL Read More
Oxurion Receives Transparency Notification from Negma Group December 21, 20220CommentsEN NL Read More
Oxurion Receives Transparency Notifications from Negma Group December 19, 20220CommentsEN NL Read More
